Clinical Trials

Conditions:   Prostate Cancer;   Renal Cancer;   Brain Cancer;   ALS
Intervention:  
Sponsor:   Duke University
Recruiting - verified September 2016

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: Ezogabine;   Drug: Placebo
Sponsors:   Brian Wainger;   ALS Association;   GlaxoSmithKline;   Harvard University;   Massachusetts General Hospital
Recruiting - verified December 2016

Conditions:   Shigellosis;   Bacillary Dysentery
Intervention:   Biological: Shigella flexneri 2a InvaplexAR
Sponsor:   U.S. Army Medical Research and Materiel Command
Recruiting - verified August 2016

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Device: Faros Sensor (FS) and LifeInsight Hub;   Device: Fast Fix electrode patch;   Procedure: Quantitative Measure of Speech (Core Phase Only)
Sponsors:   GlaxoSmithKline;   McLaren Applied Technologies
Active, not recruiting - verified July 2016

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: Darunavir;   Drug: Ritonavir;   Drug: Raltegravir;   Drug: Zidovudine
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Enrolling by invitation - verified October 12, 2016

Condition:   Leukemia
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Radiation: Total Body Irradiation (TBI);   Drug: Thymoglobulin;   Biological: Stem Cell Infusion;   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Decitabine;   Drug: Cytarabine;   Drug: Idarubicin
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified September 2016

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Interventions:   Drug: Pimozide 2 mg per day;   Drug: Pimozide 4 mg per day;   Drug: Placebo (Lactose tablet)
Sponsors:   University of Calgary;   Hotchkiss Brain Institute, University of Calgary
Active, not recruiting - verified October 2016

Condition:   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Interventions:   Procedure: AlloHCT for Young/MSD;   Procedure: AlloHCT for Young/MUD&FMD;   Procedure: AlloHCT for Old/MSD;   Procedure: AlloHCT for Old/MUD&FMD
Sponsor:   Asan Medical Center
Terminated - verified July 2016

Conditions:   Acute Myeloid Leukemia;   B-Cell Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia;   Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Myeloproliferative Neoplasm;   T-Cell Non-Hodgkin Lymphoma

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Intervention:   Drug: Drug: F 18 T807
Sponsor:   Washington University School of Medicine
Recruiting - verified May 2016